VTU Technology bringing Pichia advances to BIO Europe and ESIB

news-releasesVALIDOGEN GmbH
October 24th 2016

Grambach, Austria: Protein expression specialist VTU Technology will be showcasing its latest advances in exploiting its leading Pichia pastoris recombinant expression technology at the high prestige BIO-Europe biotechnology partnering conference in November.

The innovative CRO will also attend the European Summit of Industrial Biotechnology (ESIB) meeting in Graz from 14-16 November.

VTU Technology Head of Business Development, Dr. Thomas Purkarthofer will represent the company at both events, offering out-licensing and co-development opportunities for several recombinant proteins based on the Pichia pastoris platform.

Recombinant proteins

“We plan to use networking opportunities and face-to-face meetings at BIO Europe to present latest advances and applications of our world-leading Pichia pastoris expression system for higher efficiency production of a wide range of biologics and other recombinant proteins,” said Dr. Purkarthofer.

“With the advances we’ve made during the past year, we can show customers and potential partners an even broader and more powerful Pichia pastoris protein production platform, with astonishing protein yields achieved over the past year,” he declared.

Tailored glycoproteins

In addition, we’ll be able to talk about some very interesting new enhancements to VTU’s recently introduced glycoprotein production services that provide fertile ground for productive partnerships for companies seeking competitive advantage,” Dr. Purkarthofer said.

“These are based on a combination of RCT´s Pichia GlycoSwitch® system boosted by our own Pichia pastoris platform for the production of tailored glycoproteins with human-like glycoforms,” he added.

About VTU Technology

VTU Technology, a leading contract research and development company, offers the broadest toolbox and most versatile technology platform available for Pichia pastoris recombinant protein expression / production enabling highest productivities delivering up to 25 g/L of secreted protein (record productivities of 35 g/L) within a few weeks development time.

VTU´s yield-enhancing Pichia pastoris expression platform is based on its proprietary AOX1 promoter libraries and set of expression enhancing helper factors, several platform strains with different genetic backgrounds, elaborated cloning and transformation protocols, a high-throughput screening and cultivation regime combined with excellent know-how in fermentation and downstream process development for maximization of product yield and overall process performance.

Headquartered in Grambach, near Graz, Austria, VTU Technology is a private company and a subsidiary of VTU Holding, an Austrian enterprise that combines several technology and engineering companies in chemistry, pharma and life science as well as in the energy industries.

More information at: www.vtu-technology.com and www.vtu.com

About BIO-Europe 2016

The BIO-Europe® Conference is the flagship conference for EBD Group, providing life science companies with high caliber knowledge sharing and partnering opportunities.

BIO-Europe 2016 is a three-day event opening November 7 at Cologne’s Köln Messe – Congress Center North.

This year´s BIO-Europe partnering event will again draw over 3,000 industry attendees from nearly 60 countries, representing more than 1,800 companies for three days of high level networking.

More information at: https://ebdgroup.knect365.com/bioeurope/

About ESIB 2016

The European Summit of Industrial Biotechnology (ESIB) provides a new European communication platform for industrial biotechnology, bringing together scientific topics with industrial needs and priorities, economic demands, funding resources and political aspirations in an event that combines knowledge-sharing, networking and recreation.

ESIB 2016 is a three-day event opening November 14 at the Messecongress in the center of the ancient Austrian university city of Graz.

The event is organized by the Austrian Centre of Industrial Biotechnology (ACIB) with more information available at: https://esib2016.wordpress.com